HistoSonics vs Rejoni

HistoSonics vs Rejoni, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: HistoSonics is on 47/100 and Rejoni on 46/100.

HistoSonicsDeveloping a new histotripsy therapeutic platform for cancer treatment.
Try HistoSonics
Rejoni logo
RejoniElevating uterine health through innovative biomaterial therapies.
Try Rejoni

Where each one leads

HistoSonics

  • agent readiness: 37/100 against 26/100
  • domain rating: 48/100 against 17/100
  • funding raised: $140M against $25.0M

Rejoni

Leads on none of the measures we hold for both companies.

At a glance

MeasureHistoSonicsRejoni
What it isDeveloping a new histotripsy therapeutic platform for cancer treatment.Elevating uterine health through innovative biomaterial therapies.
CategoryBiotechnology, Medical Devices, HealthTech, OncologyBiotechnology, Healthcare, Medical Devices, Biotech
Sells toBusiness modelB2BB2B
OfferingHardwareHardware
FoundedNot published2018
HeadquartersMinneapolis, USABedford, USA
StatusActiveActive

Size, funding and growth

MeasureHistoSonicsRejoni
EmployeesNot published19
Total funding$140M$25.0M
Latest roundFunding RoundFunding Round
Valuation$1.1BNot published
LinkedIn followersNot published870

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureHistoSonicsRejoni
StartupHub scoreOur 0-100 rating47/10046/100
Traction40/10050/100
Search visibility5/10035/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (37/100)F (26/100)
Domain ratingLink authority, 0-10048/10017/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureHistoSonicsRejoni
CDNNot detectedCloudflare
CMSWordPressWebflow
FrameworksJqueryNot detected
AnalyticsGoogle Tag ManagerNot detected
Support stackHubSpotNot detected

What users say

MeasureHistoSonicsRejoni
Reddit sentimentThreads we track4 positive, 0 negative across 6 threadsNot published
HistoSonics
Tumor-destroying soundwaves receive FDA approval for liver treatment in humans. The US FDA has approved HistoSonics to market a liver cancer treatment using histotripsy, an ultrasound-based technology developed at the University of Michigan
r/STEW_ScTecEngWorld

HistoSonics vs Rejoni: common questions

Which is better, HistoSonics or Rejoni?

On our 0-100 score HistoSonics rates higher (47/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.

How do HistoSonics and Rejoni compare on the numbers?

HistoSonics leads on agent readiness (37/100 against 26/100), domain rating (48/100 against 17/100), funding raised ($140M against $25.0M).

What do real users say about HistoSonics and Rejoni?

HistoSonics: 4 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/STEW_ScTecEngWorld.

Read the full HistoSonics review and pricing or the Rejoni review and pricing. You can also browse other HistoSonics alternatives we track.